Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-01-31 Sale | 2022-02-02 5:08 pm | Indaptus Therapeutics Inc. | INDP | Newman Michael James CSO and Director Director 10% Owner | 20,000 | $5.0021 | $100,043 | 1,368,356 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-09 Option Award | 2024-10-10 4:05 pm | N/A 2034-10-09 | Indaptus Therapeutics Inc. | INDP | Newman Michael James CSO and Director Director 10% Owner | 75,000 | $0 | 75,000 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-23 4:15 pm | N/A 2034-01-22 | Indaptus Therapeutics Inc. | INDP | Newman Michael James CSO and Director Director 10% Owner | 43,250 | $0 | 43,250 (Direct) | View |
| 2023-01-18 Option Award | 2023-01-20 4:05 pm | N/A 2033-01-18 | Indaptus Therapeutics Inc. | INDP | Newman Michael James CSO and Director Director 10% Owner | 43,250 | $0 | 43,250 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 4:31 pm | N/A 2032-01-26 | Indaptus Therapeutics Inc. | INDP | Newman Michael James CSO and Director Director 10% Owner | 43,350 | $0 | 43,350 (Direct) | View |
| 2021-08-04 Option Award | 2021-08-06 5:00 pm | N/A 2031-08-04 | Indaptus Therapeutics Inc. | INDP | Newman Michael James CSO and Director Director 10% Owner | 290,000 | $0 | 290,000 (Direct) | View |
Ownership | 2021-08-06 4:35 pm | N/A N/A | Indaptus Therapeutics Inc. | INDP | Newman Michael James Chief Scientific Officer 10% Owner | 0 | $0 | 1,388,356 (Indirect) | View |